Mkts

TG Therapeutics, Inc.

NASDAQ: TGTX
$61.18+3.10 (+5.34%)
As of Oct 30, 4:00 PM ET

Key statistics

Day range
58.0061.76
52-week range
26.7661.76
Today
Open58.15
Previous close61.18
Volume—
Valuation
Market cap9.36B
P/E ratio21.21×
EPS (TTM)2.75
Income & risk
Dividend / yield—
Beta1.81
Avg volume2.00M
Discussion

TGTX News

Stories mentioning TGTX from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue204,918192,574161,709141,148120,856108,18583,87973,466
Cost of Goods Sold33,51038,14228,09318,93815,54115,4009,3418,304
Gross Profit171,408154,432133,616122,210105,31592,78574,53865,162
Operating Expenses
Research & Development48,39641,19340,87831,78246,36223,87520,13817,556
Sales General & Admin88,21762,74563,37355,58550,33138,96141,96638,790
Total Operating Expenses
Operating Income (Loss)34,79550,49429,36534,8438,62229,94912,4348,816
Interest Income
Interest Expense
Other Expense2,3871,1323,2652,7933,6032,4352,6661,712
Pretax Income20,36345,09325,90930,9205,46825,4534,2686,551
Tax Provision586.0022,056(364,986)2,733408.002,122388.00(328.00)
Net Income (Loss)19,77723,037390,89528,1875,06023,3313,8806,879
Earnings Per Share (Basic)0.140.162.690.190.030.160.030.05
Earnings Per Share (Diluted)0.120.142.430.170.030.150.020.04
Weighted Average Shares Outstanding (Basic)144,439144,317145,417146,740146,678145,317145,102144,727
Weighted Average Shares Outstanding (Diluted)160,062161,413160,998162,559162,769160,336160,714159,424

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About TGTX

TG Therapeutics, Inc. (NASDAQ: TGTX) is a stock listed on the Nasdaq Stock Market under the ticker symbol TGTX. It last traded at $61.18 (Oct 30, 2026, 4:00 PM ET), up 5.3% on the day. That gives TG Therapeutics a market capitalisation of $9.4B and a price-to-earnings ratio of 21.2.

Over the past 52 weeks TGTX has traded between $26.76 and $61.76.

Revenue for the quarter ended Mar 31, 2026 was $204.9M; net income $19.8M. Revenue was up 69.6% from $120.9M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$204.9M$19.8M9.7%
Dec 31, 2025$192.6M$23.0M12.0%
Sep 30, 2025$161.7M$390.9M241.7%
Jun 30, 2025$141.1M$28.2M20.0%

From TG Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…